ORBIMED ADVISORS LLC 13D and 13G filings for TELA Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-25 4:24 pm Sale |
2024-10-23 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 1,182,717 4.800% |
-941,550 (-44.32%) |
Filing |
| 2024-10-01 5:35 pm Sale |
2024-09-27 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 2,124,267 8.600% |
-313,700 (-12.87%) |
Filing |
| 2024-07-02 4:58 pm Sale |
2024-06-28 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 2,437,967 9.900% |
-428,300 (-14.94%) |
Filing |
| 2023-04-21 5:03 pm Sale |
2023-04-19 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 2,866,267 11.900% |
-192,000 (-6.28%) |
Filing |
| 2022-08-19 4:17 pm Unchanged |
2022-08-18 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 3,058,267 16.500% |
0 (Unchanged) |
Filing |
| 2020-07-01 5:31 pm Unchanged |
2020-06-30 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 3,058,267 21.200% |
0 (Unchanged) |
Filing |